XML 54 R16.htm IDEA: XBRL DOCUMENT v2.4.0.6
SEGMENT INFORMATION
 9 Months Ended
Dec. 29, 2012
Segment Reporting [Abstract]  
SEGMENT INFORMATION
SEGMENT INFORMATION
Segment Definition Criteria

We manage our business on the basis of one operating segment: the design, manufacture, and marketing of blood management solutions. Our chief operating decision-maker uses consolidated results to make operating and strategic decisions. Manufacturing processes, as well as the regulatory environment in which we operate, are largely the same for all product lines.

Enterprise-Wide Disclosures about Product and Services

We have four global product families: plasma, blood center, hospital, and software solutions. Beginning August 1, 2012, we integrated the whole blood business as part of the blood center product family.
Our products include manual blood collection kits, devices and the disposable single-use sterile kits used with these devices. Disposables include the plasma, blood center, and hospital product families. Plasma consists of the disposables used to perform apheresis for the separation of whole blood components and subsequent collection of plasma to be used as a raw material for biologically derived pharmaceuticals (also known as source plasma). Blood center consists of manual collection kits and disposables which separate whole blood for the subsequent collection of platelets, plasma, red cells, or a combination of these components for transfusion to patients. Hospital consists of surgical disposables (principally the Cell Saver® and Cell Saver Elite ® autologous blood recovery systems targeted toward procedures that involve rapid, high volume blood loss such as cardiovascular surgeries and the cardioPAT® cardiovascular perioperative autotransfusion system designed to remain with the patient following cardiovascular surgery to recover blood and the patient’s red cells to prepare them for reinfusion), the OrthoPAT® orthopedic perioperative autotransfusion system designed to operate both during and after orthopedic surgery to recover and wash the patient’s red cells to prepare them for reinfusion, and diagnostics products (principally the TEG® Thrombelastograph® hemostasis analyzer used to help assess a surgical patient’s blood clotting ability before, during and after surgery). Software solutions include information technology platforms that assist blood centers, plasma centers, and hospitals to more effectively manage regulatory compliance and operational efficiency.
Revenues from External Customers:
 
Three Months Ended
(in thousands)
December 29,
2012
 
December 31,
2011
Disposable revenues
 
 
 
Plasma disposables
$
68,102

 
$
69,040

Blood center disposables
 
 
 
Platelet
45,139

 
44,383

Red cell
11,752

 
12,162

            Whole blood
54,894

 
—

 
111,785

 
56,545

Hospital disposables
 
 
 
Surgical
18,900

 
17,333

OrthoPAT
7,090

 
7,755

Diagnostics
6,761

 
5,681

 
32,751

 
30,769

Disposables revenue
212,638

 
156,354

Software solutions
16,008

 
15,849

Equipment & other
18,749

 
18,957

Net revenues
$
247,395

 
$
191,160


 
Nine Months Ended
(in thousands)
December 29,
2012
 
December 31,
2011
Disposable revenues
 
 
 
Plasma disposables
$
200,657

 
$
196,206

Blood center disposables
 
 
 
Platelet
125,579

 
123,888

Red cell
35,738

 
35,676

       Whole blood
83,514

 
—

 
244,831

 
159,564

Hospital disposables
 
 
 
Surgical
55,965

 
49,281

OrthoPAT
22,276

 
22,804

Diagnostics
20,196

 
16,955

 
98,437

 
89,040

Disposables revenue
543,925

 
444,810

Software solutions
51,354

 
51,208

Equipment & other
46,769

 
45,156

Net revenues
$
642,048

 
$
541,174